BAYER AG-Exch receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Bayer AG PK (BAYRY)
Bayer AG PK stock price live, this page displays OTC BAYRY stock exchange data. View the BAYRY premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Bayer AG PK real time stock price chart below.
What Is the Bayer AG PK Stock Price Today?
The Bayer AG PK stock price today is 14.44.
What Is the Stock Symbol for Bayer AG PK?
The stock symbol for Bayer AG PK is "BAYRY."
What Stock Exchange Does Bayer AG PK Trade On?
Bayer AG PK is listed and trades on the OTC Markets stock exchange.
Is Bayer AG PK a Good Stock to Buy?
Determining whether Bayer AG PK—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the BAYRY quote. (ISIN: US0727303028)
What Is the Bayer AG PK Stock Price Today?
The Bayer AG PK stock price today is 14.44.
What Is the Stock Symbol for Bayer AG PK?
The stock symbol for Bayer AG PK is "BAYRY."
What Stock Exchange Does Bayer AG PK Trade On?
Bayer AG PK is listed and trades on the OTC Markets stock exchange.
Is Bayer AG PK a Good Stock to Buy?
Determining whether Bayer AG PK—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the BAYRY quote. (ISIN: US0727303028)
OTC Markets
Symbol | Exchange | Currency | |||
|---|---|---|---|---|---|
| BAYRY | · | OTC Markets | · | USD | |
| 0P6S | · | London | · | EUR | |
| BAYGn | · | Derived | · | EUR | |
| BAYGn | · | Xetra | · | EUR | |
| BAYGn | · | Switzerland | · | CHF | |
| BAYG | · | Milan | · | EUR | |
| BAYGn | · | Vienna | · | EUR | |
| BAYG | · | Budapest | · | HUF | |
| BAY1 | · | Warsaw | · | PLN | |
| BAYN | · | Bucharest | · | RON | |
| BAYNN | · | Mexico | · | MXN | |
| BAYGn | · | Frankfurt | · | EUR | |
| BAYGn | · | TradeGate | · | EUR | |
| BAYNd | · | BATS Europe | · | EUR | |
| BAYGn | · | Dusseldorf | · | EUR | |
| BAYGn | · | Hamburg | · | EUR | |
| BAYNN | · | BIVA | · | MXN |
Currency in USD
14.44
+0.12(+0.84%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
14.36
14.60
52 wk Range
7.42
15.23
BAYRY is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
14.3614.60
52 wk Range
7.4215.23
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.17%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.17%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
BAYRY Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Price Target
15.97
Upside
+10.60%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Prominent player in the Pharmaceuticals industry
Why is Bayer stock rallying today?- Investing.com
- BAYER AG-Exch receives Investment Bank Analyst Rating Update
- Investing.com
Pro 
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Analyst Ratings
2 Buy
2 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 15.97
(+10.60% Upside)
Bayer AG PK Earnings Call Summary for Q2/2026
- Bayer Q2 2026 EPS of €0.2735 beat estimates by 24.15%; revenue of €12.52B topped forecasts by 1.71%, driving shares up 4.72% premarket.
- Company reiterated full-year guidance and lowered year-end net debt target to €29-30B from €32-33B, aided by €3B Apollo equity investment.
- First-half free cash flow negative €2.7B due to €2.5B litigation payouts; net debt rose to €33.6B but expected to decline by year-end.
- Pharma growth driven by NUBEQA and KERENDIA; asundexian launch expected late 2026/early 2027 in U.S. and China as potential stroke care standard.
- CEO Anderson stated Bayer is 'in a better position now than we've been at any point in the last few years to make strategic choices.'
Last Updated: 08/04/2026, 09:26 PM
Read Full TranscriptEarnings
Latest Release
Aug 04, 2026
EPS / Forecast
0.27 / 0.22
Revenue / Forecast
12.53B / 12.31B
Compare BAYRY to Peers and Sector
Metrics to compare | BAYRY | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipBAYRYPeersSector | |
|---|---|---|---|---|
P/E Ratio | −28.2x | 2.5x | −0.4x | |
PEG Ratio | −0.57 | 0.15 | 0.00 | |
Price/Book | 1.7x | 1.5x | 2.6x | |
Price / LTM Sales | 1.1x | 1.7x | 3.1x | |
Upside (Analyst Target) | 10.5% | 17.8% | 48.8% | |
Fair Value Upside | Unlock | −0.1% | 5.7% | Unlock |
Bayer Aktiengesellschaft operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment provides prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment offers nonprescription over-the-counter medicines for self-medication and self-care; nutritional supplements; allergy, cough, and cold; dermatology; pain and cardiovascular risk prevention; and digestive health products. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solutions, and pest and weed management products, as well as customer services for agriculture. It also engages in the breeding, propagation, and production/processing of seeds, including seed dressing. The company distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. Bayer Aktiengesellschaft has a strategic alliance with The University of Colorado Anschutz, along with UCHealth and Children's Hospital Colorado to advance drug development and clinical trials. Bayer Aktiengesellschaft has a strategic alliance Henry Ford Health. Bayer Aktiengesellschaft was founded in 1863 and is based in Leverkusen, Germany.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Bayer AG PK (BAYRY) Stock Price Today?
The Bayer AG PK stock price today is 14.44 USD.
What Stock Exchange Does Bayer AG PK Trade On?
Bayer AG PK is listed and trades on the OTC Markets.
What Is the Stock Symbol for Bayer AG PK?
The stock symbol for Bayer AG PK is "BAYRY."
Does Bayer AG PK Pay Dividends? What’s The Current Dividend Yield?
The Bayer AG PK dividend yield is 0.17%.
What Is the Bayer AG PK Market Cap?
As of today, Bayer AG PK market cap is 56.55B USD.
What Is Bayer AG PK's Earnings Per Share (TTM)?
The Bayer AG PK EPS (TTM) is -1.77.
When Is the Next Bayer AG PK Earnings Date?
Bayer AG PK will release its next earnings report on Nov 03, 2026.
From a Technical Analysis Perspective, Is BAYRY a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Bayer AG PK Stock Split?
Bayer AG PK has split 3 times.
How Many Employees Does Bayer AG PK Have?
Bayer AG PK has 87830 employees.
What is the current trading status of Bayer AG PK (BAYRY)?
As of Aug 09, 2026, Bayer AG PK (BAYRY) is trading at a price of 14.44 USD, with a previous close of 14.32 USD. The stock has fluctuated within a day range of 14.36 USD to 14.60 USD, while its 52-week range spans from 7.42 USD to 15.23 USD.
What Is Bayer AG PK (BAYRY) Price Target According to Analysts?
The average 12-month price target for Bayer AG PK is 15.97 USD, with a high estimate of 16.68 USD and a low estimate of 15.3 USD. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +10.60% Upside potential.
What Is the BAYRY Premarket Price?
BAYRY's last pre-market stock price is 14.45 USD. The pre-market share volume is 18,920.00, and the stock has decreased by 0.13, or 0.91%.
What Is the BAYRY After Hours Price?
BAYRY's last after hours stock price is 13.07 USD, the stock has decreased by -0.90, or -6.44%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.